Division of Surgery and Interventional Science, Royal Free Hospital, University College London, London, UK.
Anaesthesia. 2015 Jan;70 Suppl 1:20-8, e6-8. doi: 10.1111/anae.12918.
Pre-operative anaemia is a relatively common finding, affecting a third of patients undergoing elective surgery. Traditionally associated with chronic disease, management has historically focused on the use of blood transfusion as a solution for anaemia in the peri-operative period. Data from large series now suggest that anaemia is an independent risk associated with poor outcome in both cardiac and non-cardiac surgery. Furthermore, blood transfusion does not appear to ameliorate this risk, and in fact may increase the risk of postoperative complications and hospital length of stay. Consequently, there is a need to identify, diagnose and manage pre-operative anaemia to reduce surgical risk. Discoveries in the pathways of iron metabolism have found that chronic disease can cause a state of functional iron deficiency leading to anaemia. The key iron regulatory protein hepcidin, activated in response to inflammation, inhibits absorption of iron from the gastrointestinal tract and further reduces bioavailability of iron stores for red cell production. Consequently, although iron stores (predominantly ferritin) may be normal, the transport of iron either from the gastrointestinal tract or iron stores to the bone marrow is inhibited, leading to a state of 'functional' iron deficiency and subsequent anaemia. Since absorption from the gastrointestinal tract is blocked, increasing oral iron intake is ineffective, and studies are now looking at the role of intravenous iron to treat anaemia in the surgical setting. In this article, we review the incidence and impact of anaemia on the pre-operative patient. We explain how anaemia may be caused by functional iron deficiency, and how iron deficiency anaemia may be diagnosed and treated.
术前贫血是一种相对常见的情况,影响三分之一接受择期手术的患者。传统上与慢性疾病相关,管理历史上侧重于在围手术期使用输血作为贫血的解决方案。现在来自大型系列的数据表明,贫血是心脏和非心脏手术不良结果的独立危险因素。此外,输血似乎并不能改善这种风险,实际上可能会增加术后并发症和住院时间的风险。因此,需要识别、诊断和治疗术前贫血以降低手术风险。铁代谢途径的发现表明,慢性疾病可导致功能性缺铁状态,导致贫血。关键的铁调节蛋白铁调素在炎症反应中被激活,抑制从胃肠道吸收铁,并进一步降低用于红细胞生成的铁储存的生物利用度。因此,尽管铁储存(主要是铁蛋白)可能正常,但铁从胃肠道或铁储存到骨髓的转运受到抑制,导致“功能性”缺铁和随后的贫血。由于胃肠道吸收受阻,增加口服铁摄入无效,目前正在研究静脉内铁在外科治疗贫血中的作用。在本文中,我们回顾了术前患者贫血的发生率和影响。我们解释了贫血如何由功能性缺铁引起,以及如何诊断和治疗缺铁性贫血。